Health
Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2 – News-Medical.Net
A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened, according to results from an Emory Vaccine Center study.
A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened, according to results from an Emory Vaccine Center study.
The findings have implications for the effort to develop vaccines against multiple strains of flu, as well as the current push for vaccines against SARS-CoV-2.
The Emory study was a test of what happens when the body sees something new – in…
-
General13 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
Noosa News13 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
Noosa News23 hours agoMenulog announces shock closure in Australia after ‘challenging circumstances’
-
Noosa News15 hours agoMirvac to sell site to Irvine Group